AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Pomerantz LLP Investigating Encompass Health Corporation Securities Fraud Claims.
ByAinvest
Tuesday, Sep 2, 2025 10:05 am ET1min read
Pomerantz LLP is investigating claims on behalf of Encompass Health Corporation investors regarding alleged securities fraud or unlawful business practices. The investigation concerns Encompass' performance on safety measures, with The New York Times reporting that its for-profit hospitals have below-average rates of potentially preventable readmissions to general hospitals. Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Pomerantz LLP, a leading firm in corporate, securities, and antitrust class litigation, has announced an investigation into claims on behalf of investors of Encompass Health Corporation (NYSE: EHC). The investigation focuses on whether Encompass and its officers and/or directors have engaged in securities fraud or other unlawful business practices.The investigation was prompted by a report published by The New York Times on July 15, 2025, which cited federal data and inspection reports alleging that for-profit hospitals run by Encompass perform below average on key safety measures. The article reported that Encompass owns many rehab facilities with worse rates of potentially preventable, unplanned readmissions to general hospitals, including 34 facilities that Medicare rated as having statistically significantly worse rates of potentially preventable readmissions. The article also described several "alarming mistakes" leading to fatalities in the care of Encompass-owned facilities [2].
Following the publication of the article, Encompass's stock price fell by $12.39 per share, or 10.35%, closing at $107.28 per share on July 15, 2025. Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, for more information about the class action.
Pomerantz LLP is acknowledged for its expertise in securities class actions and has a history of recovering multimillion-dollar damages on behalf of class members [2].
References:
[1] https://www.globenewswire.com/news-release/2025/08/29/3141606/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Encompass-Health-Corporation-EHC.html
[2] https://www.globenewswire.com/news-release/2025/08/29/3141606/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Encompass-Health-Corporation-EHC.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet